Organization

ATXA Therapeutics

1 clinical trial

Clinical trial

Phase 1, Randomised, Open-label, 3-way Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics (With Food Effect), and Relative Bioavailability of NTP42:KVA4 Given as a Capsule, Compared With a Liquid, in Healthy Volunteers

Status: Recruiting, Estimated PCD: 2023-12-01